In the study conducted by Merza et al. [20], the concentration of IL‐6 was significantly higher in moderate COVID‐19 and severe cases of COVID‐19 groups compared to the control and recovered groups, which confirmed our results. This evidence concerns the gene IL6 and COVID-19.